ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-10P16913
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Porcine Circovirus Type 2 PCV2 Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
BUY CHAPTERS

Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Research Report 2025

Code: QYRE-Auto-10P16913
Report
May 2025
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Zoetis Animal Health
Boehringer Ingelheim
Merck Animal Health
Ceva Santé Animale
MSD Animal Health
SPAH
Sichuan Huapai Bio-pharmaceutical
Guangdong Winsun Bio Pharmaceutical
Wuhan Keqian Biology
Shanghai Hile Bio-Technology
Harbin Pharmaceutical Group Bio-vaccine
ringpu
Weike Biotechnology
CHINA ANIMAL HUSBANDRY INDUSTRY
Shandong Huahong Bioengineering

Porcine Circovirus Type 2 (PCV2) Vaccine Market

The global market for Porcine Circovirus Type 2 (PCV2) Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Porcine circovirus type 2 mainly causes multisystem failure disease characterized by generalized lymphadenopathy in pigs, clinically manifested as multisystem failure syndrome, porcine dermatitis and nephritic syndrome, and porcine respiratory disease syndrome in weaned piglets , sow reproductive disorders, necrotizing lymphadenitis, granulomatous enteritis and exudative epidermatitis, etc. The vaccine can significantly improve the production performance of pig farms, significantly increase the growth rate, survival rate and feed utilization rate of pigs at all stages, and significantly reduce the incidence of disease and death rate.
North American market for Porcine Circovirus Type 2 (PCV2) Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Porcine Circovirus Type 2 (PCV2) Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Porcine Circovirus Type 2 (PCV2) Vaccine include Zoetis Animal Health, Boehringer-Ingelheim, Merck Animal Health, Ceva Santé Animale, MSD Animal Health, SPAH, Nanjing Tianbang Biological Technology, Sichuan Huapai Bio-pharmaceutical, Guangdong Winsun Bio Pharmaceutical, Wuhan Keqian Biology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Porcine Circovirus Type 2 (PCV2) Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Porcine Circovirus Type 2 (PCV2) Vaccine.
The Porcine Circovirus Type 2 (PCV2) Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Porcine Circovirus Type 2 (PCV2) Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Porcine Circovirus Type 2 (PCV2) Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Porcine Circovirus Type 2 (PCV2) Vaccine Market Report

Report Metric Details
Report Name Porcine Circovirus Type 2 (PCV2) Vaccine Market
Segment by Type
  • WH Type
  • LG Type
  • SH Type
  • SD Type
  • ZJ C Type
  • Others
Segment by Application
  • Piglets
  • Adults Pigs
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Zoetis Animal Health, Boehringer-Ingelheim, Merck Animal Health, Ceva Santé Animale, MSD Animal Health, SPAH, Nanjing Tianbang Biological Technology, Sichuan Huapai Bio-pharmaceutical, Guangdong Winsun Bio Pharmaceutical, Wuhan Keqian Biology, Shanghai Hile Bio-Technology, Harbin Pharmaceutical Group Bio-Vaccine, Ringpu, Shandong Huahong Bioengineering, Weike Biotechnology, China Animal Husbandry Industry
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Porcine Circovirus Type 2 (PCV2) Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Porcine Circovirus Type 2 (PCV2) Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Porcine Circovirus Type 2 (PCV2) Vaccine Market report?

Ans: The main players in the Porcine Circovirus Type 2 (PCV2) Vaccine Market are Zoetis Animal Health, Boehringer-Ingelheim, Merck Animal Health, Ceva Santé Animale, MSD Animal Health, SPAH, Nanjing Tianbang Biological Technology, Sichuan Huapai Bio-pharmaceutical, Guangdong Winsun Bio Pharmaceutical, Wuhan Keqian Biology, Shanghai Hile Bio-Technology, Harbin Pharmaceutical Group Bio-Vaccine, Ringpu, Shandong Huahong Bioengineering, Weike Biotechnology, China Animal Husbandry Industry

What are the Application segmentation covered in the Porcine Circovirus Type 2 (PCV2) Vaccine Market report?

Ans: The Applications covered in the Porcine Circovirus Type 2 (PCV2) Vaccine Market report are Piglets, Adults Pigs

What are the Type segmentation covered in the Porcine Circovirus Type 2 (PCV2) Vaccine Market report?

Ans: The Types covered in the Porcine Circovirus Type 2 (PCV2) Vaccine Market report are WH Type, LG Type, SH Type, SD Type, ZJ C Type, Others

1 Porcine Circovirus Type 2 (PCV2) Vaccine Market Overview
1.1 Product Definition
1.2 Porcine Circovirus Type 2 (PCV2) Vaccine by Type
1.2.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 WH Type
1.2.3 LG Type
1.2.4 SH Type
1.2.5 SD Type
1.2.6 ZJ C Type
1.2.7 Others
1.3 Porcine Circovirus Type 2 (PCV2) Vaccine by Application
1.3.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Piglets
1.3.3 Adults Pigs
1.4 Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Size Estimates and Forecasts
1.4.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue 2020-2031
1.4.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales 2020-2031
1.4.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Porcine Circovirus Type 2 (PCV2) Vaccine Market Competition by Manufacturers
2.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Porcine Circovirus Type 2 (PCV2) Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Porcine Circovirus Type 2 (PCV2) Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Porcine Circovirus Type 2 (PCV2) Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Porcine Circovirus Type 2 (PCV2) Vaccine, Date of Enter into This Industry
2.8 Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Competitive Situation and Trends
2.8.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Porcine Circovirus Type 2 (PCV2) Vaccine Players Market Share by Revenue
2.8.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Scenario by Region
3.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Region: 2020-2031
3.2.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Region: 2020-2025
3.2.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Region: 2026-2031
3.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Region: 2020-2031
3.3.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Region: 2020-2025
3.3.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Region: 2026-2031
3.4 North America Porcine Circovirus Type 2 (PCV2) Vaccine Market Facts & Figures by Country
3.4.1 North America Porcine Circovirus Type 2 (PCV2) Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Country (2020-2031)
3.4.3 North America Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Porcine Circovirus Type 2 (PCV2) Vaccine Market Facts & Figures by Country
3.5.1 Europe Porcine Circovirus Type 2 (PCV2) Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Country (2020-2031)
3.5.3 Europe Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Porcine Circovirus Type 2 (PCV2) Vaccine Market Facts & Figures by Country
3.7.1 Latin America Porcine Circovirus Type 2 (PCV2) Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Porcine Circovirus Type 2 (PCV2) Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Porcine Circovirus Type 2 (PCV2) Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Type (2020-2031)
4.1.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Type (2020-2025)
4.1.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Type (2026-2031)
4.1.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Type (2020-2031)
4.2.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Type (2020-2025)
4.2.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Type (2026-2031)
4.2.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Application (2020-2031)
5.1.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Application (2020-2025)
5.1.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Application (2026-2031)
5.1.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Application (2020-2031)
5.2.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Application (2020-2025)
5.2.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Application (2026-2031)
5.2.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Zoetis Animal Health
6.1.1 Zoetis Animal Health Company Information
6.1.2 Zoetis Animal Health Description and Business Overview
6.1.3 Zoetis Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Zoetis Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolio
6.1.5 Zoetis Animal Health Recent Developments/Updates
6.2 Boehringer-Ingelheim
6.2.1 Boehringer-Ingelheim Company Information
6.2.2 Boehringer-Ingelheim Description and Business Overview
6.2.3 Boehringer-Ingelheim Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Boehringer-Ingelheim Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolio
6.2.5 Boehringer-Ingelheim Recent Developments/Updates
6.3 Merck Animal Health
6.3.1 Merck Animal Health Company Information
6.3.2 Merck Animal Health Description and Business Overview
6.3.3 Merck Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolio
6.3.5 Merck Animal Health Recent Developments/Updates
6.4 Ceva Santé Animale
6.4.1 Ceva Santé Animale Company Information
6.4.2 Ceva Santé Animale Description and Business Overview
6.4.3 Ceva Santé Animale Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Ceva Santé Animale Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolio
6.4.5 Ceva Santé Animale Recent Developments/Updates
6.5 MSD Animal Health
6.5.1 MSD Animal Health Company Information
6.5.2 MSD Animal Health Description and Business Overview
6.5.3 MSD Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 MSD Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolio
6.5.5 MSD Animal Health Recent Developments/Updates
6.6 SPAH
6.6.1 SPAH Company Information
6.6.2 SPAH Description and Business Overview
6.6.3 SPAH Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 SPAH Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolio
6.6.5 SPAH Recent Developments/Updates
6.7 Nanjing Tianbang Biological Technology
6.7.1 Nanjing Tianbang Biological Technology Company Information
6.7.2 Nanjing Tianbang Biological Technology Description and Business Overview
6.7.3 Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolio
6.7.5 Nanjing Tianbang Biological Technology Recent Developments/Updates
6.8 Sichuan Huapai Bio-pharmaceutical
6.8.1 Sichuan Huapai Bio-pharmaceutical Company Information
6.8.2 Sichuan Huapai Bio-pharmaceutical Description and Business Overview
6.8.3 Sichuan Huapai Bio-pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sichuan Huapai Bio-pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolio
6.8.5 Sichuan Huapai Bio-pharmaceutical Recent Developments/Updates
6.9 Guangdong Winsun Bio Pharmaceutical
6.9.1 Guangdong Winsun Bio Pharmaceutical Company Information
6.9.2 Guangdong Winsun Bio Pharmaceutical Description and Business Overview
6.9.3 Guangdong Winsun Bio Pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Guangdong Winsun Bio Pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolio
6.9.5 Guangdong Winsun Bio Pharmaceutical Recent Developments/Updates
6.10 Wuhan Keqian Biology
6.10.1 Wuhan Keqian Biology Company Information
6.10.2 Wuhan Keqian Biology Description and Business Overview
6.10.3 Wuhan Keqian Biology Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Wuhan Keqian Biology Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolio
6.10.5 Wuhan Keqian Biology Recent Developments/Updates
6.11 Shanghai Hile Bio-Technology
6.11.1 Shanghai Hile Bio-Technology Company Information
6.11.2 Shanghai Hile Bio-Technology Description and Business Overview
6.11.3 Shanghai Hile Bio-Technology Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Shanghai Hile Bio-Technology Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolio
6.11.5 Shanghai Hile Bio-Technology Recent Developments/Updates
6.12 Harbin Pharmaceutical Group Bio-Vaccine
6.12.1 Harbin Pharmaceutical Group Bio-Vaccine Company Information
6.12.2 Harbin Pharmaceutical Group Bio-Vaccine Description and Business Overview
6.12.3 Harbin Pharmaceutical Group Bio-Vaccine Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Harbin Pharmaceutical Group Bio-Vaccine Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolio
6.12.5 Harbin Pharmaceutical Group Bio-Vaccine Recent Developments/Updates
6.13 Ringpu
6.13.1 Ringpu Company Information
6.13.2 Ringpu Description and Business Overview
6.13.3 Ringpu Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Ringpu Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolio
6.13.5 Ringpu Recent Developments/Updates
6.14 Shandong Huahong Bioengineering
6.14.1 Shandong Huahong Bioengineering Company Information
6.14.2 Shandong Huahong Bioengineering Description and Business Overview
6.14.3 Shandong Huahong Bioengineering Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Shandong Huahong Bioengineering Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolio
6.14.5 Shandong Huahong Bioengineering Recent Developments/Updates
6.15 Weike Biotechnology
6.15.1 Weike Biotechnology Company Information
6.15.2 Weike Biotechnology Description and Business Overview
6.15.3 Weike Biotechnology Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Weike Biotechnology Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolio
6.15.5 Weike Biotechnology Recent Developments/Updates
6.16 Nanjing Tianbang Biological Technology
6.16.1 Nanjing Tianbang Biological Technology Company Information
6.16.2 Nanjing Tianbang Biological Technology Description and Business Overview
6.16.3 Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolio
6.16.5 Nanjing Tianbang Biological Technology Recent Developments/Updates
6.17 China Animal Husbandry Industry
6.17.1 China Animal Husbandry Industry Company Information
6.17.2 China Animal Husbandry Industry Description and Business Overview
6.17.3 China Animal Husbandry Industry Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.17.4 China Animal Husbandry Industry Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolio
6.17.5 China Animal Husbandry Industry Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Porcine Circovirus Type 2 (PCV2) Vaccine Industry Chain Analysis
7.2 Porcine Circovirus Type 2 (PCV2) Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Porcine Circovirus Type 2 (PCV2) Vaccine Production Mode & Process Analysis
7.4 Porcine Circovirus Type 2 (PCV2) Vaccine Sales and Marketing
7.4.1 Porcine Circovirus Type 2 (PCV2) Vaccine Sales Channels
7.4.2 Porcine Circovirus Type 2 (PCV2) Vaccine Distributors
7.5 Porcine Circovirus Type 2 (PCV2) Vaccine Customer Analysis
8 Porcine Circovirus Type 2 (PCV2) Vaccine Market Dynamics
8.1 Porcine Circovirus Type 2 (PCV2) Vaccine Industry Trends
8.2 Porcine Circovirus Type 2 (PCV2) Vaccine Market Drivers
8.3 Porcine Circovirus Type 2 (PCV2) Vaccine Market Challenges
8.4 Porcine Circovirus Type 2 (PCV2) Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Zoetis Animal Health
Boehringer Ingelheim
Merck Animal Health
Ceva Santé Animale
MSD Animal Health
SPAH
Sichuan Huapai Bio-pharmaceutical
Guangdong Winsun Bio Pharmaceutical
Wuhan Keqian Biology
Shanghai Hile Bio-Technology
Harbin Pharmaceutical Group Bio-vaccine
ringpu
Weike Biotechnology
CHINA ANIMAL HUSBANDRY INDUSTRY
Shandong Huahong Bioengineering
List of Tables
 Table 1. Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses) of Key Manufacturers (2020-2025)
 Table 5. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Porcine Circovirus Type 2 (PCV2) Vaccine Average Price (US$/Dose) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Porcine Circovirus Type 2 (PCV2) Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Porcine Circovirus Type 2 (PCV2) Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Porcine Circovirus Type 2 (PCV2) Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Porcine Circovirus Type 2 (PCV2) Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Porcine Circovirus Type 2 (PCV2) Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Porcine Circovirus Type 2 (PCV2) Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Region (2020-2025) & (K Doses)
 Table 18. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Region (2026-2031) & (K Doses)
 Table 20. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Country (2020-2025) & (K Doses)
 Table 27. North America Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Country (2026-2031) & (K Doses)
 Table 28. North America Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Country (2020-2025) & (K Doses)
 Table 32. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Country (2026-2031) & (K Doses)
 Table 33. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Region (2020-2025) & (K Doses)
 Table 37. Asia Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Region (2026-2031) & (K Doses)
 Table 38. Asia Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Country (2020-2025) & (K Doses)
 Table 42. Latin America Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Country (2026-2031) & (K Doses)
 Table 43. Latin America Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Country (2020-2025) & (K Doses)
 Table 47. Middle East and Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Country (2026-2031) & (K Doses)
 Table 48. Middle East and Africa Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses) by Type (2020-2025)
 Table 51. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses) by Type (2026-2031)
 Table 52. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Porcine Circovirus Type 2 (PCV2) Vaccine Price (US$/Dose) by Type (2020-2025)
 Table 59. Global Porcine Circovirus Type 2 (PCV2) Vaccine Price (US$/Dose) by Type (2026-2031)
 Table 60. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses) by Application (2020-2025)
 Table 61. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses) by Application (2026-2031)
 Table 62. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Porcine Circovirus Type 2 (PCV2) Vaccine Price (US$/Dose) by Application (2020-2025)
 Table 69. Global Porcine Circovirus Type 2 (PCV2) Vaccine Price (US$/Dose) by Application (2026-2031)
 Table 70. Zoetis Animal Health Company Information
 Table 71. Zoetis Animal Health Description and Business Overview
 Table 72. Zoetis Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 73. Zoetis Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Product
 Table 74. Zoetis Animal Health Recent Developments/Updates
 Table 75. Boehringer-Ingelheim Company Information
 Table 76. Boehringer-Ingelheim Description and Business Overview
 Table 77. Boehringer-Ingelheim Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 78. Boehringer-Ingelheim Porcine Circovirus Type 2 (PCV2) Vaccine Product
 Table 79. Boehringer-Ingelheim Recent Developments/Updates
 Table 80. Merck Animal Health Company Information
 Table 81. Merck Animal Health Description and Business Overview
 Table 82. Merck Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 83. Merck Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Product
 Table 84. Merck Animal Health Recent Developments/Updates
 Table 85. Ceva Santé Animale Company Information
 Table 86. Ceva Santé Animale Description and Business Overview
 Table 87. Ceva Santé Animale Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 88. Ceva Santé Animale Porcine Circovirus Type 2 (PCV2) Vaccine Product
 Table 89. Ceva Santé Animale Recent Developments/Updates
 Table 90. MSD Animal Health Company Information
 Table 91. MSD Animal Health Description and Business Overview
 Table 92. MSD Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 93. MSD Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Product
 Table 94. MSD Animal Health Recent Developments/Updates
 Table 95. SPAH Company Information
 Table 96. SPAH Description and Business Overview
 Table 97. SPAH Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 98. SPAH Porcine Circovirus Type 2 (PCV2) Vaccine Product
 Table 99. SPAH Recent Developments/Updates
 Table 100. Nanjing Tianbang Biological Technology Company Information
 Table 101. Nanjing Tianbang Biological Technology Description and Business Overview
 Table 102. Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 103. Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Product
 Table 104. Nanjing Tianbang Biological Technology Recent Developments/Updates
 Table 105. Sichuan Huapai Bio-pharmaceutical Company Information
 Table 106. Sichuan Huapai Bio-pharmaceutical Description and Business Overview
 Table 107. Sichuan Huapai Bio-pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 108. Sichuan Huapai Bio-pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Product
 Table 109. Sichuan Huapai Bio-pharmaceutical Recent Developments/Updates
 Table 110. Guangdong Winsun Bio Pharmaceutical Company Information
 Table 111. Guangdong Winsun Bio Pharmaceutical Description and Business Overview
 Table 112. Guangdong Winsun Bio Pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 113. Guangdong Winsun Bio Pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Product
 Table 114. Guangdong Winsun Bio Pharmaceutical Recent Developments/Updates
 Table 115. Wuhan Keqian Biology Company Information
 Table 116. Wuhan Keqian Biology Description and Business Overview
 Table 117. Wuhan Keqian Biology Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 118. Wuhan Keqian Biology Porcine Circovirus Type 2 (PCV2) Vaccine Product
 Table 119. Wuhan Keqian Biology Recent Developments/Updates
 Table 120. Shanghai Hile Bio-Technology Company Information
 Table 121. Shanghai Hile Bio-Technology Description and Business Overview
 Table 122. Shanghai Hile Bio-Technology Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 123. Shanghai Hile Bio-Technology Porcine Circovirus Type 2 (PCV2) Vaccine Product
 Table 124. Shanghai Hile Bio-Technology Recent Developments/Updates
 Table 125. Harbin Pharmaceutical Group Bio-Vaccine Company Information
 Table 126. Harbin Pharmaceutical Group Bio-Vaccine Description and Business Overview
 Table 127. Harbin Pharmaceutical Group Bio-Vaccine Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 128. Harbin Pharmaceutical Group Bio-Vaccine Porcine Circovirus Type 2 (PCV2) Vaccine Product
 Table 129. Harbin Pharmaceutical Group Bio-Vaccine Recent Developments/Updates
 Table 130. Ringpu Company Information
 Table 131. Ringpu Description and Business Overview
 Table 132. Ringpu Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 133. Ringpu Porcine Circovirus Type 2 (PCV2) Vaccine Product
 Table 134. Ringpu Recent Developments/Updates
 Table 135. Shandong Huahong Bioengineering Company Information
 Table 136. Shandong Huahong Bioengineering Description and Business Overview
 Table 137. Shandong Huahong Bioengineering Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 138. Shandong Huahong Bioengineering Porcine Circovirus Type 2 (PCV2) Vaccine Product
 Table 139. Shandong Huahong Bioengineering Recent Developments/Updates
 Table 140. Weike Biotechnology Company Information
 Table 141. Weike Biotechnology Description and Business Overview
 Table 142. Weike Biotechnology Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 143. Weike Biotechnology Porcine Circovirus Type 2 (PCV2) Vaccine Product
 Table 144. Weike Biotechnology Recent Developments/Updates
 Table 145. Nanjing Tianbang Biological Technology Company Information
 Table 146. Nanjing Tianbang Biological Technology Description and Business Overview
 Table 147. Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 148. Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Product
 Table 149. Nanjing Tianbang Biological Technology Recent Developments/Updates
 Table 150. China Animal Husbandry Industry Company Information
 Table 151. China Animal Husbandry Industry Description and Business Overview
 Table 152. China Animal Husbandry Industry Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 153. China Animal Husbandry Industry Porcine Circovirus Type 2 (PCV2) Vaccine Product
 Table 154. China Animal Husbandry Industry Recent Developments/Updates
 Table 155. Key Raw Materials Lists
 Table 156. Raw Materials Key Suppliers Lists
 Table 157. Porcine Circovirus Type 2 (PCV2) Vaccine Distributors List
 Table 158. Porcine Circovirus Type 2 (PCV2) Vaccine Customers List
 Table 159. Porcine Circovirus Type 2 (PCV2) Vaccine Market Trends
 Table 160. Porcine Circovirus Type 2 (PCV2) Vaccine Market Drivers
 Table 161. Porcine Circovirus Type 2 (PCV2) Vaccine Market Challenges
 Table 162. Porcine Circovirus Type 2 (PCV2) Vaccine Market Restraints
 Table 163. Research Programs/Design for This Report
 Table 164. Key Data Information from Secondary Sources
 Table 165. Key Data Information from Primary Sources
 Table 166. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Porcine Circovirus Type 2 (PCV2) Vaccine
 Figure 2. Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Share by Type: 2024 & 2031
 Figure 4. WH Type Product Picture
 Figure 5. LG Type Product Picture
 Figure 6. SH Type Product Picture
 Figure 7. SD Type Product Picture
 Figure 8. ZJ C Type Product Picture
 Figure 9. Others Product Picture
 Figure 10. Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Share by Application: 2024 & 2031
 Figure 12. Piglets
 Figure 13. Adults Pigs
 Figure 14. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales (2020-2031) & (K Doses)
 Figure 17. Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price (US$/Dose) & (2020-2031)
 Figure 18. Porcine Circovirus Type 2 (PCV2) Vaccine Report Years Considered
 Figure 19. Porcine Circovirus Type 2 (PCV2) Vaccine Sales Share by Manufacturers in 2024
 Figure 20. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Porcine Circovirus Type 2 (PCV2) Vaccine Players: Market Share by Revenue in Porcine Circovirus Type 2 (PCV2) Vaccine in 2024
 Figure 22. Porcine Circovirus Type 2 (PCV2) Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Country (2020-2031)
 Figure 25. North America Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Country (2020-2031)
 Figure 26. United States Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Country (2020-2031)
 Figure 29. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Region (2020-2031)
 Figure 37. China Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Southeast Asia Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Porcine Circovirus Type 2 (PCV2) Vaccine by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Porcine Circovirus Type 2 (PCV2) Vaccine by Type (2020-2031)
 Figure 56. Global Porcine Circovirus Type 2 (PCV2) Vaccine Price (US$/Dose) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Porcine Circovirus Type 2 (PCV2) Vaccine by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Porcine Circovirus Type 2 (PCV2) Vaccine by Application (2020-2031)
 Figure 59. Global Porcine Circovirus Type 2 (PCV2) Vaccine Price (US$/Dose) by Application (2020-2031)
 Figure 60. Porcine Circovirus Type 2 (PCV2) Vaccine Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Porcine Circovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Swine Circovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Porcine Circovirus Diseases Vaccine Market Research Report 2024
Global Porcine Circovirus Mycoplasma Hyopneumoniae Vaccine Market Research Report 2024
Blue Eye Disease Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Swine Mycoplasma Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Swine Reproductive and Respiratory Syndrome Vaccine Market Insights Forecast to 2030
Vaccine for Porcine Reproductive and Respiratory Syndrome PRRS Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pseudorabies Virus Vaccine Market Insights Forecast to 2030
Swine Streptococcus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Porcine Epidemic Diarrhea Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Swine Transmissble Gastroenteritis Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hog Cholera Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Porcine Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Porcine Reproductive Respiratory Syndrome PRRS Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Research Report 2024
Global Porcine Reproductive and Respiratory Syndrome Test Kit Market Research Report 2024
Swine Epidemic Diarrhea Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Blue Ear Pig Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pneumococcal 13 valent Conjugate Vaccine Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions